| Disease Name |
Glioblastoma |
| Nocoding RNA Name |
hsa-miR-145 |
| Expression Pattern |
down-regulated |
| Species |
Homo sapiens |
| Detection Methods |
qRT-PCR,Luciferase Reporter Assay,Immunoblotting Analysis etc. |
| Target |
JAM-A |
| Tissue |
brain |
| Treatment |
N/A
|
| PubMed ID |
26374689 |
| Year |
2015 |
| Detail Description |
Using patient-derived glioblastoma CSCs, we confirmed that JAM-A is suppressed by miR-145. CSCs expressed low levels of miR-145, and its introduction decreased self-renewal through reductions in AKT signaling and stem cell marker (SOX2, OCT4, and NANOG) expression; JAM-A overexpression rescued these effects. |
|